<?xml version="1.0" encoding="UTF-8"?>
<ref id="B4-pharmaceuticals-13-00283">
 <label>4.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reno</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Tanoli</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Bree</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Daphna-Iken</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Cui</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Maloney</surname>
    <given-names>S.E.</given-names>
   </name>
   <name>
    <surname>Wozniak</surname>
    <given-names>D.F.</given-names>
   </name>
   <name>
    <surname>Fisher</surname>
    <given-names>S.J.</given-names>
   </name>
  </person-group>
  <article-title>Antecedent glycemic control reduces severe hypoglycemia-induced neuronal damage in diabetic rats</article-title>
  <source>Am. J. Physiol. Metab.</source>
  <year>2013</year>
  <volume>304</volume>
  <fpage>1331</fpage>
  <lpage>1337</lpage>
  <pub-id pub-id-type="doi">10.1152/ajpendo.00084.2013</pub-id>
  <?supplied-pmid 23592483?>
  <pub-id pub-id-type="pmid">23592483</pub-id>
 </element-citation>
</ref>
